Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/24 20:00 | 6/21/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Brown Ryan Edward | MA | O | EVP,GC | 2 | M.dm | 7,771 | 113.11 | 0 | 69 | 17 | D | |||||||||||||||
6/25/24 20:00 | 6/25/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Brown Ryan Edward | MA | O | EVP,GC | 2 | S.dm | -7,771 | 113.11 | 0 | -69 | 17 | D | |||||||||||||||
6/25/24 20:00 | 6/21/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Rodino-Klapac Louise | MA | O | Head of | 1 | M.d | 0 | 0.00 | 0 | 6 | 9 | 72 | D | ||||||||||||||
6/25/24 20:00 | 6/21/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Murray Dallan | MA | O | Chief Cu | 2 | M.d | 509 | 51.48 | 0 | 10 | 81 | 22 | D | ||||||||||||||
6/25/24 20:00 | 6/21/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Estepan Ian Michael | MA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 6 | 19 | 40 | D | ||||||||||||||
6/25/24 20:00 | 6/21/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Arif Bilal | MA | O | Chief Te | 2 | M.dm | 1,918 | 106.51 | 0 | 18 | 17 | D | |||||||||||||||
6/25/24 20:00 | 6/24/24 | SRPT | Health | Drug | Pharmaceutical Preparations | Arif Bilal | MA | O | Chief Te | 2 | S.dm | -1,918 | 106.51 | 0 | -18 | 17 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |